XELOX+Bevacizumab Followed by Capecitabine+Bevacizumab+Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Adenocarcinoma

This study is currently recruiting participants.

Verified November 2007 by Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials

Sponsor:

Collaborator:

Hoffmann-La Roche

Information provided by:

Associacio catalana per a la recerca oncologica i les seves implicacions sanitaries i socials

ClinicalTrials.gov Identifier:

NCT00557713

First received: November 13, 2007

Last updated: NA

Last verified: November 2007

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	October 2013
Estimated Primary Completion Date:	No date given